1. Market Research
  2. > Allergan Limited – Product Pipeline Review – 2013

Allergan Limited – Product Pipeline Review – 2013

  • May 2013
  • -
  • Global Markets Direct
  • -
  • 14 pages

Allergan Limited – Product Pipeline Review – 2013

Summary

Global Market Direct’s pharmaceuticals report, “Allergan Limited - Product Pipeline Review - 2013” provides data on the Allergan Limited’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Allergan Limited’s corporate website, SEC filings, investor presentations and featured press releases, both from Allergan Limited and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Allergan Limited - Brief Allergan Limited overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Allergan Limited human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Allergan Limited with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Allergan Limited’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Allergan Limited’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Allergan Limited in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Allergan Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Allergan Limited.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Allergan Limited and identify potential opportunities in those areas.

Table Of Contents

Allergan Limited - Product Pipeline Review - 2013
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Allergan Limited Snapshot 4
Key Information 4
Key Facts 4
Allergan Limited - Research and Development Overview 5
Key Therapeutic Areas 5
Allergan Limited - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Allergan Limited - Pipeline Products Glance 9
Allergan Limited Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Allergan Limited - Drug Profiles 10
AGN-195263 10
Product Description 10
Mechanism of Action 10
RandD Progress 10
Allergan Limited - Pipeline Products by Route of Administration 11
Allergan Limited - Locations And Subsidiaries 12
Head Office 12
Appendix 13
Methodology 13
Coverage 13
Secondary Research 13
Primary Research 13
Expert Panel Validation 13
Contact Us 14
Disclaimer 14

List of Tables

Allergan Limited, Key Information 4
Allergan Limited, Key Facts 4
Allergan Limited - Pipeline by Indication, 2013 6
Allergan Limited - Pipeline by Stage of Development, 2013 7
Allergan Limited - Monotherapy Products in Pipeline, 2013 8
Allergan Limited - Phase II, 2013 9
Allergan Limited - Pipeline By Route of Administration, 2013 11

List of Figures

Allergan Limited - Pipeline by Indication, 2013 6
Allergan Limited - Pipeline by Stage of Development, 2013 7
Allergan Limited - Monotherapy Products in Pipeline, 2013 8

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.